Improving HIV treatment and testing for young people in rural Africa
Strategic antiretroviral therapy and HIV testing for youth in rural Africa
This study is looking to improve HIV treatment and testing for young people in rural Uganda and Kenya by trying out a new approach that fits their needs better, and it will involve the community to help those who haven't been tested or are not getting the care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10469425 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV treatment and testing for adolescents and young adults in rural Uganda and Kenya. It aims to implement a strategic combination therapy intervention that adapts to the unique developmental needs of youth, addressing barriers to care such as low testing rates and poor retention in treatment. The study will involve community participation to engage young people who are either undiagnosed or not receiving adequate care. By utilizing a cluster randomized controlled trial, the effectiveness of this innovative approach will be compared to standard care.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 10-24 living with HIV in rural areas of Uganda and Kenya.
Not a fit: Patients outside the age range of 10-24 or those not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve HIV treatment outcomes and quality of life for young people living with HIV in rural Africa.
How similar studies have performed: Previous research has shown success in community-based interventions for HIV treatment, indicating that this approach has potential for positive outcomes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Havlir, Diane V — University of California, San Francisco
- Study coordinator: Havlir, Diane V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.